Hughes Financial Services’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.8K Sell
435
-1
-0.2% -$30 ﹤0.01% 333
2026
Q2
$10.4K Sell
436
-10
-2% -$223 ﹤0.01% 364
2026
Q1
$10.9K Buy
446
+10
+2% +$328 ﹤0.01% 314
2025
Q4
$17K Buy
436
+1
+0.2% +$32 ﹤0.01% 242
2025
Q3
$15.1K Hold
435
– – ﹤0.01% 252
2025
Q2
$8.6K Hold
435
– – ﹤0.01% 329
2025
Q1
$8.6K Buy
+435
New +$10.8K ﹤0.01% 340

Other funds holding CSTL

Hughes Financial Services's CSTL Position: Q3 2026 in Review

Hughes Financial Services reduced its Castle Biosciences (CSTL) stake by 0.23% in Q3 2026, selling an estimated $30 and leaving 435 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

Hughes Financial Services first reported a position in CSTL in Q1 2025 and has held it in 7 quarters since. The position peaked at $17K in Q4 2025. 201 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Hughes Financial Services held 435 shares of Castle Biosciences worth $16.8K as of Q3 2026.
  • Hughes Financial Services sold 1 Castle Biosciences share in Q3 2026, an estimated $30.
  • Castle Biosciences made up ﹤0.01% of Hughes Financial Services's portfolio in Q3 2026, its #333 holding.
  • Hughes Financial Services first reported a position in Castle Biosciences in Q1 2025 and has held it in 7 quarters since.
  • Hughes Financial Services's Castle Biosciences position peaked at $17K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Hughes Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.